Dr. Robert J. Widmer, MD, PHD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 17
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 213
Licensed in Texas since 2017, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TX license R4625 (first issued 2017; canc non-renewal)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor Scott & White Medical Center - Temple Temple, TX
- Baylor Scott & White Medical Center Plano Plano, TX
- Baylor Scott & White the Heart Hospital Plano Plano, TX
- Baylor Scott and White Medical Center Mckinney Mc Kinney, TX
- Baylor Scott and White the Heart Hospital Corinth Denton, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 213
- Services billed
- 486
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 112 | 106 |
| Established patient office or other outpatient visit, 30-39 minutes | 101 | 81 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 48 | 22 |
| New patient office or other outpatient visit, 45-59 minutes | 48 | 48 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 45 | 45 |
| Critical care, first 30-74 minutes | 34 | 17 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 29 | 29 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | 24 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 26 | 26 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Temple, TX | 115 |
| Losartan Potassium Other prescribers in Temple, TX | 73 |
| Carvedilol Other prescribers in Temple, TX | 68 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Temple, TX | 66 |
| Lisinopril Other prescribers in Temple, TX | 59 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Temple, TX | 52 |
| Metoprolol Succinate Other prescribers in Temple, TX | 43 |
| Furosemide Other prescribers in Temple, TX | 43 |
| Spironolactone Other prescribers in Temple, TX | 43 |
| Rosuvastatin Calcium Other prescribers in Temple, TX | 40 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 75 payments worth $24,724 in total to this clinician.
| Medtronic, Inc. | $10,871 |
|---|---|
| Abbott Laboratories | $8,994 |
| Philips North America LLC | $3,425 |
| Shockwave Medical, Inc | $617 |
| Penumbra, Inc. | $164 |
| Amgen Inc. | $156 |
| E.r. Squibb & Sons, L.l.c. | $154 |
| Acist Medical Systems, Inc. | $104 |
| Consulting Fee | $14,110 |
|---|---|
| Travel and Lodging | $4,077 |
| Speaking at a medical education program | $3,500 |
| Food and Beverage | $3,037 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Oct 17, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $8,550 |
| Abbott Laboratories Feb 5, 2025 | Speaking at a medical education program SUPERA · Structural Heart | $2,500 |
| Philips North America LLC Mar 5, 2025 | Consulting Fee IGT Devices Undivided · Medical Device | $2,360 |
| Abbott Laboratories Apr 4, 2025 | Consulting Fee PRESSUREWIRE · Structural Heart | $2,200 |
| Abbott Laboratories Jan 7, 2025 | Travel and Lodging COROFLOW · Vascular · travel to Wichita Falls, TX · in-kind | $1,750 |
| Abbott Laboratories Jan 7, 2025 | Speaking at a medical education program COROFLOW · Vascular | $1,000 |
| Abbott Laboratories Jan 7, 2025 | Consulting Fee COROFLOW · Vascular | $1,000 |
| Medtronic, Inc. Sep 11, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $418 |
| Medtronic, Inc. Sep 12, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $408 |
| Philips North America LLC Feb 5, 2025 | Travel and Lodging Coronary Undivided · Medical Device · travel to Atlanta, GA | $372 |
All 20 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Nov 19, 2025 | Travel and Lodging travel to Plano, TX · in-kind | $35.60 |
| Abbott Laboratories Oct 23, 2025 | Travel and Lodging COROFLOW · Vascular · travel to San Fransisco, CA · in-kind | $333 |
| Medtronic, Inc. Oct 17, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $8,550 |
| Medtronic, Inc. Oct 6, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $66.34 |
| Medtronic, Inc. Sep 12, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $408 |
| Medtronic, Inc. Sep 11, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $418 |
| Medtronic, Inc. Jul 25, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $18.71 |
| Medtronic, Inc. Jul 23, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $258 |
| Medtronic, Inc. Jul 23, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $4.68 |
| Abbott Laboratories Apr 4, 2025 | Consulting Fee PRESSUREWIRE · Structural Heart | $2,200 |
| Philips North America LLC Mar 5, 2025 | Consulting Fee IGT Devices Undivided · Medical Device | $2,360 |
| Philips North America LLC Feb 25, 2025 | Travel and Lodging Coronary Undivided · Medical Device · travel to Atlanta, GA | $319 |
| Abbott Laboratories Feb 5, 2025 | Speaking at a medical education program SUPERA · Structural Heart | $2,500 |
| Philips North America LLC Feb 5, 2025 | Travel and Lodging Coronary Undivided · Medical Device · travel to Atlanta, GA | $372 |
| Philips North America LLC Feb 5, 2025 | Travel and Lodging Coronary Undivided · Medical Device · travel to Arlington, VA | $42.19 |
| Philips North America LLC Feb 4, 2025 | Travel and Lodging LM Undivided · Medical Device · travel to Arlington, VA | $42.19 |
| Abbott Laboratories Jan 7, 2025 | Travel and Lodging COROFLOW · Vascular · travel to Wichita Falls, TX · in-kind | $1,750 |
| Abbott Laboratories Jan 7, 2025 | Speaking at a medical education program COROFLOW · Vascular | $1,000 |
| Abbott Laboratories Jan 7, 2025 | Consulting Fee COROFLOW · Vascular | $1,000 |
| Abbott Laboratories Jan 7, 2025 | Travel and Lodging COROFLOW · Vascular · travel to Wichita Falls, TX · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $115,135 in research payments for these studies, mostly to the institutions running them.
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W. L. Gore & Associates, Inc. · Recruiting · NCT03821129 - A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels
M.a. Med Alliance S.a.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.